The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-Acetylamino-N-[(S)-1-((S)-1-carbamoyl-pentylcarbamoyl)-2-(4-sulfooxy-phenyl)-ethyl]-succinamic acid ID: ALA175257
PubChem CID: 23646469
Max Phase: Preclinical
Molecular Formula: C21H30N4O10S
Molecular Weight: 530.56
Molecule Type: Protein
Associated Items:
Names and Identifiers Canonical SMILES: CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(C)=O)C(N)=O
Standard InChI: InChI=1S/C21H30N4O10S/c1-3-4-5-15(19(22)29)24-20(30)16(25-21(31)17(11-18(27)28)23-12(2)26)10-13-6-8-14(9-7-13)35-36(32,33)34/h6-9,15-17H,3-5,10-11H2,1-2H3,(H2,22,29)(H,23,26)(H,24,30)(H,25,31)(H,27,28)(H,32,33,34)/t15-,16-,17-/m0/s1
Standard InChI Key: VYEUAVNMANWCSE-ULQDDVLXSA-N
Molfile:
RDKit 2D
36 36 0 0 1 0 0 0 0 0999 V2000
5.4292 -6.1000 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.5542 -2.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6917 -2.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2667 -2.0292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4042 -2.4292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8417 -2.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8375 -1.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -2.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1292 -2.4417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8292 -2.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1167 -0.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 -6.1000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1292 -3.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1167 -2.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4292 -5.2750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4292 -6.9250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6875 -1.2000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5542 -3.2667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -3.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8292 -3.2542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2542 -6.1042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5958 -1.2042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8417 -3.6792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5417 -2.0167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1917 -5.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3875 -3.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1167 0.0333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1917 -3.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9667 -4.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3792 -5.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 -4.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5875 -3.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1125 -1.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8250 -0.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8250 0.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5375 0.4583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 0
3 8 1 0
4 8 1 0
5 3 1 0
6 2 1 0
6 7 1 1
8 19 1 6
9 6 1 0
10 14 1 0
11 7 1 0
12 1 1 0
13 9 1 0
14 5 1 0
15 1 2 0
16 1 2 0
17 3 2 0
18 2 2 0
19 26 1 0
20 10 2 0
21 1 1 0
22 11 2 0
23 13 2 0
24 10 1 0
25 12 1 0
26 28 1 0
27 11 1 0
28 31 2 0
29 30 1 0
30 25 2 0
31 25 1 0
32 13 1 0
14 33 1 1
34 33 1 0
35 34 1 0
36 35 1 0
29 26 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 530.56Molecular Weight (Monoisotopic): 530.1683AlogP: -0.96#Rotatable Bonds: 15Polar Surface Area: 231.29Molecular Species: ACIDHBA: 8HBD: 6#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 7#RO5 Violations (Lipinski): 3CX Acidic pKa: -2.30CX Basic pKa: ┄CX LogP: -2.87CX LogD: -6.56Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.15Np Likeness Score: 0.28
References 1. Larsen SD, Stevens FC, Lindberg TJ, Bodnar PM, O'Sullivan TJ, Schostarez HJ, Palazuk BJ, Bleasdale JE.. (2003) Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activity., 13 (5): [PMID:12617932 ] [10.1016/s0960-894x(02)01065-x ] 2. Kousaxidis A, Petrou A, Lavrentaki V, Fesatidou M, Nicolaou I, Geronikaki A.. (2020) Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus., 207 [PMID:32871344 ] [10.1016/j.ejmech.2020.112742 ]